PaulKlenermanLab

@PKlenermanLab

Official Twitter account of the Klenerman lab (not Paul himself). We work on CD161++/MAIT cell biology, HCV & SARS-CoV-2 immune defence, and memory inflation.

Joined September 2021

125 Following 664 Followers 91 Posts

Latest posts 5

PaulKlenermanLab @PKlenermanLab Dec 9, 2023

Very interesting paper on the effect of N1-methylpseudouridylation of mRNA on translation fidelity nature.com/articles/s4158…

www.nature.com N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting Nature - A study demonstrates that nucleotide modifications in mRNA-based therapeutics can lead to +1 ribosomal frameshifting during translation, yielding products that can trigger immune responses.

PaulKlenermanLab @PKlenermanLab Jun 4, 2022

Throwback to #CD1MR12022 @PKlenermanLab cinnamon bun hunt and crazy golf in the Gothenburg sun

PaulKlenermanLab @PKlenermanLab May 26, 2022

Congratulations to Dr. Lucy Garner for winning a price for the best short talk in Gothenburg! #CD1MR12022 @CellsMait

PaulKlenermanLab @PKlenermanLab Nov 12, 2021

Our postdoc @TheLucyGarner has been awarded a Career Enhancing Grant by the BSI. This is an excellent new scheme that offers flexible and personalised funding for career development. #CareersInImmunology #careerdevelopment #funding

British Society for Immunology @britsocimm Nov 12, 2021

📣 We’re proud to announce the BSI Career Enhancing Grants winners!

Congratulations to our 17 members who have been awarded #funding to advance their #careerdevelopment!

Read the full list & discover how this pilot scheme supports #CareersInImmunology 👉bit.ly/3F7P37n

View quoted post on X

PaulKlenermanLab @PKlenermanLab Oct 16, 2021

Our @pitchstudy comparing standard and extended dosing intervals of @pfizer BNT162b2 mRNA vaccine is out now @CellCellPress. Great collaboration with @AlexRichter3 @Susannajd @chrisjaduncan @LanceTurtle @Thushan_deSilva @Carroll_Lab_Ox and Screaton lab. cell.com/cell/fulltext/…

www.cell.com Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine After giving a primary dose, delaying administration of a second dose of BNT162b2 COVID-19 vaccine up to 6–14 weeks continues to provide strong protection and contributes to favorable antibody, B...